CLASS II Device recall · Reported 6 Jul 2016 · FDA Enforcement Report

Choledochoscope Intended to provide optical visualization recalled

Pentax Medical is recalling Choledochoscope Intended to provide optical visualization of and therapeutic access to, distributed nationwide in the US. The recall was initiated on 6 Apr 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel #'s FCP-8P and FCP-9P
Quantity recalled50 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2067-2016
FDA event ID
73894
Recalling firm
Pentax Medical, Montvale, NJ
Classification
Class II
Status
Terminated
Recall initiated
6 Apr 2016
FDA classified
28 Jun 2016
Reported
6 Jul 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

6 Apr 2016Recall initiated by company
28 Jun 2016Classified by FDA+83 days
6 Jul 2016Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel.

Product as listed by the FDA

Choledochoscope Intended to provide optical visualization of and therapeutic access to the Biliary Tree. This anatomy includes, but is not restricted to, the organs, tissues and subsystems: Common Bile, Hepatic, Cystic and Pancreatic Ducts. The instrument is introduced via the working channel of a Duodenoscope positioned for access to the Common bile Duct when indications consistent with the need for procedure are observed in adult and pediatric patient populations.

Where it was distributed

Worldwide Distribution - US (Nation Wide) including Puerto Rico and Internationally to Denmark, Guam

Nationwide Puerto Rico

Questions about this recall

Is Choledochoscope Intended to provide optical visualization of and therapeutic access to recalled?

Yes. Pentax Medical recalled Choledochoscope Intended to provide optical visualization of and therapeutic access to on 6 Apr 2016. The recall is Class II and its status is Terminated. Recall number Z-2067-2016.

Why was it recalled?

Pentax has become aware that operational/cleaning accessories and therapeutic devices (e.g., clips, stents, balloons, etc.) can become lodged in an endoscope's instrument channel.

Which lots are affected?

Model #'s FCP-8P and FCP-9P

Where was it sold?

Worldwide Distribution - US (Nation Wide) including Puerto Rico and Internationally to Denmark, Guam

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Pentax Medical

All 26

Other Heart & Vascular Devices recalls

All 6,199